Deltaphar SA
2.8 FTEDeltaphar reported total assets of €1.14m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026), with 2.8 full-time equivalents.
The score of Deltaphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +69 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Deltaphar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 22 Oct 2024
- Year ended 31 Dec 2022filed on 01 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Deltaphar's financial analysis
- Solvency-0.5%sector median: 37.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Deltaphar
Deltaphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0461.576.379
- VAT number
- BE0461576379
- Peppol
- Registered · 0208:0461576379 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 03 Oct 1997
- Registered office
- 1160 Auderghem
- Size
- Micro · 2.8 FTE
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Deltaphar (SA) has been based in Auderghem since 1997, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 15,318 € and equity of −5,970 €; its revenue is not published. With 2.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -0.5%, below the median of its sector (37.6%).
Companies similar to Deltaphar
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- POP Pharma Retail sale of pharmaceutical products Ternat · balance sheet €1.14m
- Chaspierre Holding Retail sale of pharmaceutical products Verviers · balance sheet €1.13m
- Farma Noord Retail sale of pharmaceutical products Kalmthout · balance sheet €1.12m
- Bouckaert - Mekeirele Retail sale of pharmaceutical products Zedelgem · balance sheet €1.25m
- Apotheek Bruggeman Retail sale of pharmaceutical products Ghent · balance sheet €1.17m
- Novaka Pharma Retail sale of pharmaceutical products Nivelles · balance sheet €1.10m
- Apoteek Mommaert Retail sale of pharmaceutical products Beersel · balance sheet €1.09m
Frequently asked questions about Deltaphar
What is the revenue of Deltaphar?
Deltaphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Deltaphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0461576379 for Deltaphar, if the company is VAT-registered. Its company number (CBE) is 0461.576.379.
Where is the registered office of Deltaphar?
According to the CBE register, the registered office of Deltaphar is in 1160 Auderghem.
What is the equity of Deltaphar?
At the close of the 2025 financial year, the equity of Deltaphar amounts to -5,970 €, a solvency of -0.5% of total assets.
How many people work at Deltaphar?
2.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Deltaphar?
The register lists 6 active mandates at Deltaphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Deltaphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →